LakeShore Biopharma Co., Ltd. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of CNY, except per-share amounts

	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 12 months to Mar 31, 2023
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Deferred income taxes expense (benefit)
Depreciation of property, plant and equipment
Amortization of intangible assets
Loss on disposal of property, plant and equipment
Provision for impairment of property, plant and equipment
Provision for impairment of intangible assets
Provision for impairment of other non- current assets
Share-based compensation
Bad debt provision of accounts receivable
Write-down (reversal) of inventories to net realizable value
Non-cash lease expense
Fair value changes of warrant liability
Changes in operating assets and liabilities:
Inventories
Accounts receivable
Prepaid expenses and other current assets
Accounts payable
Accrued expenses and other liabilities
Deferred government grants
Operating lease liabilities
Net cash used in operating activities
Cash flows from investing activities:
Proceeds from disposal of property, plant and equipment
Purchases of property, plant and equipment
Purchases of intangible assets
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of ordinary shares
Proceeds from business combination
Offering cost
Proceeds from bank loans and other borrowings
Repayment of bank loans and other borrowings
Net cash provided by (used in) financing activities
Effect of foreign exchange rate on cash
Net (decrease) increase in cash
Cash and restricted cash at the beginning of the year
Cash and restricted cash at the end of the year
Supplemental disclosures of cash flow information:
Income taxes paid
Interest paid
Non-cash transactions:
Accretion to redemption value of convertible redeemable preferred shares
Operating right-of-use assets recognized for related operating lease liabilities
Equity transaction from warrants
Equity transaction from preferred shares

Comments